Canada-only shipping · Free over $299 · Interac e-Transfer
BlueNexLabs Inc.Peptides for laboratory research

Glossary · 2026-09-24

Scientific lead: Alice Kay, Ph.D.

Incretin receptor ligand, laboratory term

Incretin receptor ligand, on this site, groups research solids discussed at the GLP-1 receptor, the GIP receptor, the glucagon receptor, or the amylin receptor. Those are different binding sites. A paper that studies one receptor does not document a vial aimed at another. The class note is incretin receptor ligands, and the 2026 literature map is GLP-1 peptide research in 2026.

Live SKUs are retatrutide, tirzepatide, semaglutide, and cagrilintide. Cagrilintide is filed here because purchasing offices source it with GLP-1 ligands. It is an amylin analogue, not a GLP-1 sequence. Trial readouts are not catalog specifications and they are not approvals. The retatrutide literature note is separate from the shop URL.

Frequently asked questions

Does one Certificate of Analysis cover every incretin fill?
No. Each milligram size and each compound has its own library row when a lot is published. A 10 mg report does not document a 30 mg vial.
Is an investigational trial the same as a catalog lot?
No. Public trial programmes describe sponsor materials under a protocol. A lyophilized research solid on this site is a separate object with its own lot report, if one is published.

Research-use only. BlueNex Labs does not provide medical or veterinary advice. Confirm your institution’s policies before purchase.